Skip to search formSkip to main contentSkip to account menu

HMMR gene

Known as: HYALURONAN-MEDIATED MOTILITY RECEPTOR, RHAMM, CD168 
This gene plays a role in the mediation of motility, which effects migration and other cellular processes.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Fragments of the extracellular matrix component hyaluronan (HA) promote tissue inflammation, fibrosis and tumor progression. HA… 
2012
2012
Receptor for hyaluronan (HA)-mediated motility (RHAMM) was first described as a soluble HA binding protein released by sub… 
2009
2009
Differential expression of molecules in chronic lymphocytic leukemia (CLL) may define prognostic markers and suitable targets for… 
2007
2007
The Bcr-Abl tyrosine kinase inhibitor imatinib mesylate is highly effective in the front-line treatment of chronic myeloid… 
2002
2002
Hyaluronan binding to its cellular receptors CD44 and ICAM-1 appears to enhance the malignant behavior of tumors, including… 
2001
2001
The protein RHAMM (for “receptor for hyaluronan‐mediated motility”; CD168) is a member of the hyaladherin family of hyaluronan… 
2001
2001
The CNS contains high levels of the glycosaminoglycan hyaluronan, and neural cells express a variety of proteins that are members… 
1994
1994
We have previously reported that the hyaluronan (HA) receptor RHAMM (Receptor for Mediated Motility) [Turley et al., 1991] and…